Use of inflammatory markers to guide cancer treatment

S. J. Clarke; W. Chua; M. Moore; S. Kao; V. Phan; C. Tan; K. Charles; D. C. McMillan

doi:10.1038/clpt.2011.122

Use of inflammatory markers to guide cancer treatment

S. J. Clarke, W. Chua, M. Moore, S. Kao, V. Phan, C. Tan, K. Charles, D. C. McMillan

Western Sydney University

Research output: Contribution to journal › Article › peer-review

68 Citations (Scopus)

Abstract

Patient"related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute"phase proteins C"reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.

Original language	English
Pages (from-to)	475-478
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	90
Issue number	3
DOIs	https://doi.org/10.1038/clpt.2011.122
Publication status	Published - 2011

Keywords

biomarkers
cancer
treatment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/clpt.2011.122

Cite this

@article{ec293f3c408d4403991db754716a1784,

title = "Use of inflammatory markers to guide cancer treatment",

abstract = "Patient{"}related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute{"}phase proteins C{"}reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.",

keywords = "biomarkers, cancer, treatment",

author = "Clarke, {S. J.} and W. Chua and M. Moore and S. Kao and V. Phan and C. Tan and K. Charles and McMillan, {D. C.}",

year = "2011",

doi = "10.1038/clpt.2011.122",

language = "English",

volume = "90",

pages = "475--478",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Use of inflammatory markers to guide cancer treatment

AU - Clarke, S. J.

AU - Chua, W.

AU - Moore, M.

AU - Kao, S.

AU - Phan, V.

AU - Tan, C.

AU - Charles, K.

AU - McMillan, D. C.

PY - 2011

Y1 - 2011

N2 - Patient"related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute"phase proteins C"reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.

AB - Patient"related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute"phase proteins C"reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.

KW - biomarkers

KW - cancer

KW - treatment

UR - http://hdl.handle.net/1959.7/uws:56079

U2 - 10.1038/clpt.2011.122

DO - 10.1038/clpt.2011.122

M3 - Article

SN - 0009-9236

VL - 90

SP - 475

EP - 478

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 3

ER -

Use of inflammatory markers to guide cancer treatment

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this